Does ELETRIPTAN Cause Product use in unapproved indication? 22 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Product use in unapproved indication have been filed in association with ELETRIPTAN. This represents 6.8% of all adverse event reports for ELETRIPTAN.
22
Reports of Product use in unapproved indication with ELETRIPTAN
6.8%
of all ELETRIPTAN reports
0
Deaths
8
Hospitalizations
How Dangerous Is Product use in unapproved indication From ELETRIPTAN?
Of the 22 reports, 8 (36.4%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELETRIPTAN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does ELETRIPTAN Cause?
Drug ineffective (91)
Therapeutic product effect incomplete (27)
Foetal exposure during pregnancy (25)
Migraine (24)
Headache (23)
Off label use (23)
Vomiting (23)
Nausea (21)
Treatment failure (17)
Somnolence (15)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which ELETRIPTAN Alternatives Have Lower Product use in unapproved indication Risk?
ELETRIPTAN vs ELETRIPTAN HYDROBROMIDE
ELETRIPTAN vs ELEXACAFTOR\IVACAFTOR\TEZACAFTOR
ELETRIPTAN vs ELIGLUSTAT
ELETRIPTAN vs ELIQUIS
ELETRIPTAN vs ELOSULFASE ALFA